$9.09
▲ +0.1% Today
as of Sep 4, 16:56 ET
Last 30 days
Recent Press Releases & News
Viemed Healthcare (VMD) Stock Fair Value Rises After Mixed Analyst Views On Profitability
Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands
Viemed (VMD) Q2 2026 Earnings Call Transcript
Overview
52-week range
$6.05
$13
46% of range
Avg surprise (last 1)
-33.3%
Avg reaction (last 2)
+0.3%
50% positive
Latest IV / EM
137%
EM ±21.5% · $10 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.07 | — | — | — | — | financials |
| Tue May 5, 2026 | Mar/2026 | $0.06 | $0.09 | -33.3% | 0.0% | +2.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.09 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $0.08 | — | — | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.06 | — | — | — | -1.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.04 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.04 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.06 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.04 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $78M | $75M | — | $72M | $63M | $59M | — | $58M |
| Cost of revenue | $33M | $33M | — | $31M | $26M | $26M | — | $24M |
| Gross profit | $45M | $43M | — | $41M | $37M | $33M | — | $34M |
| Operating income | $4M | $4M | — | $6M | $5M | $4M | — | $6M |
| Net income | $3M | $3M | — | $4M | $3M | $3M | — | $4M |
| EPS (diluted) | $0.07 | $0.06 | — | $0.09 | $0.08 | $0.06 | — | $0.10 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11M | $10M | $14M | $11M | $20M | $10M | $18M | $11M |
| Inventory | $5M | $5M | $5M | $5M | $4M | $5M | $4M | $4M |
| Total current assets | $54M | $50M | $48M | $50M | $55M | $49M | $53M | $48M |
| Total assets | $204M | $197M | $199M | $202M | $185M | $178M | $177M | $170M |
| Long-term debt | $6M | $8M | $11M | $20M | $3M | $4M | $4M | $4M |
| Total liabilities | $58M | $52M | $56M | $67M | $43M | $41M | $44M | $43M |
| Total equity | $144M | $146M | $142M | $134M | $142M | $137M | $131M | $127M |